Quantitative assessment of promoter hypermethylation during breast cancer development

American Journal of Pathology

Volumn 160, Issue 2, 2002, Pages 605-612

  Lehmann, Ulrich ^a   Länger, Florian ^a   Feist, Henning ^a   Glöckner, Sabine ^a   Hasemeier, Britta ^a   Kreipe, Hans ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER INVASION; CELL PROLIFERATION; EPITHELIUM CELL; GENE DELETION; GROWTH REGULATION; HUMAN; HUMAN TISSUE; MALIGNANT TRANSFORMATION; METHYLATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ASSAY; RISK ASSESSMENT; TUMOR GROWTH;

EID: 0036170908     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64880-8     Document Type: Article

References (43)

1. The hallmarks of cancer
2. Methylation matters
3. Methylation-induced repression-belts, braces, and chromatin
4. DNA methylation and chromatin modification
5. Cancer epigenetics comes of age
6. Identification of expressed genes by laser-mediated manipulation of single cells
7. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands
8. Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE)
9. COBRA: A sensitive and quantitative DNA methylation assay
10. Quantitative analysis of aberrant p16 methylation using real-time quantitative methylation-specific polymerase chain reaction
11. MethyLight: A high-throughput assay to measure DNA methylation
12. Quantitative analysis of promoter hypermethylation in laser-microdissected archival specimens
13. Analyses of the genomic methylation status of the human cyclin A1 promoter by a novel real-time PCR-based methodology
14. Advances in quantitative PCR technology: 5′ nuclease assays
15. DNA methylation in breast cancer
16. Prognostic classification of breast ductal carcinoma-in-situ
17. Detection of gene amplification in archival breast cancer specimens by laser-assisted microdissection and quantitative real-time polymerase chain reaction
18. Loss of p16INK4 expression by methylation is associated with lifespan extension of human mammary epithelial cells
19. Progressive region-specific de novo methylation of the p16 CpG island in primary human mammary epithelial cell strains during escape from M(O) growth arrest
20. Hypermethylaticn of the CpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers
21. Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation
22. High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer
23. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma
24. Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma
25. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients
26. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients
27. Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma
28. Positive display of methylated sites: A novel method for the detection of promoter methylation
29. A gene hypermethylation profile of human cancer
30. Aberrant methylation of the estrogen receptor and E-cadherin 5′ CpG islands increases with malignant progression in human breast cancer
31. Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR
32. Methylation in the p53 promoter is a supplementary route to breast carcinogenesis: Correlation between CpG methylation in the p53 promoter and the mutation of the p53 gene in the progression from ductal carcinoma in situ to invasive ductal carcinoma
33. Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer
34. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3
35. Increased expression of cyclin D2 during multiple states of growth arrest in primary and established cells
36. Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1)
37. INK4a gene expression and methylation in primary breast cancer: Overexpression of p161NK4a messenger RNA is a marker of poor prognosis
38. Molecular portraits of human breast tumours
39. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers
40. Preferential loss of expression of p16(INK4a) rather than p19(ARF) in breast cancer
41. Aberrant DNA methylation of the p161NK4a gene in plasma DNA of breast cancer patients
42. Methylation of the p16(Ink4a) tumor suppressor gene 5′-CpG island in breast cancer
43. Hypomethylation and increased gene expression of p16INK4a in primary and metastatic breast carcinoma as compared to normal breast tissue